Literature DB >> 19549601

Substrate-guided design of a potent and selective kallikrein-related peptidase inhibitor for kallikrein 4.

Joakim E Swedberg1, Laura V Nigon, Janet C Reid, Simon J de Veer, Carina M Walpole, Carson R Stephens, Terry P Walsh, Thomas K Takayama, John D Hooper, Judith A Clements, Ashley M Buckle, Jonathan M Harris.   

Abstract

Human kallikrein-related peptidase 4 (KLK4/prostase), a trypsin-like serine protease, is a potential target for prostate cancer treatment because of its proteolytic ability to activate many tumorigenic and metastatic pathways including the protease activated receptors (PARs). Currently there are no KLK4-specific small-molecule inhibitors available for therapeutic development. Here we re-engineer the naturally occurring sunflower trypsin inhibitor to selectively block the proteolytic activity of KLK4 and prevent stimulation of PAR activity in a cell-based system. The re-engineered inhibitor was designed using a combination of molecular modeling and sparse matrix substrate screening.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19549601     DOI: 10.1016/j.chembiol.2009.05.008

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  32 in total

Review 1.  Circular proteins from plants and fungi.

Authors:  Ulf Göransson; Robert Burman; Sunithi Gunasekera; Adam A Strömstedt; K Johan Rosengren
Journal:  J Biol Chem       Date:  2012-06-14       Impact factor: 5.157

Review 2.  Targeting protein-protein interfaces using macrocyclic peptides.

Authors:  Meng Gao; Kui Cheng; Hang Yin
Journal:  Biopolymers       Date:  2015-07       Impact factor: 2.505

3.  Structural insights into the role of the cyclic backbone in a squash trypsin inhibitor.

Authors:  Norelle L Daly; Louise Thorstholm; Kathryn P Greenwood; Gordon J King; K Johan Rosengren; Begoña Heras; Jennifer L Martin; David J Craik
Journal:  J Biol Chem       Date:  2013-10-29       Impact factor: 5.157

4.  Albumins and their processing machinery are hijacked for cyclic peptides in sunflower.

Authors:  Joshua S Mylne; Michelle L Colgrave; Norelle L Daly; Aurelie H Chanson; Alysha G Elliott; Emily J McCallum; Alun Jones; David J Craik
Journal:  Nat Chem Biol       Date:  2011-03-20       Impact factor: 15.040

Review 5.  Using backbone-cyclized Cys-rich polypeptides as molecular scaffolds to target protein-protein interactions.

Authors:  Dipankar Chaudhuri; Teshome Aboye; Julio A Camarero
Journal:  Biochem J       Date:  2019-01-11       Impact factor: 3.857

Review 6.  Bile salt hydrolases: Structure and function, substrate preference, and inhibitor development.

Authors:  Zixing Dong; Byong H Lee
Journal:  Protein Sci       Date:  2018-09-24       Impact factor: 6.725

7.  High-affinity cyclic peptide matriptase inhibitors.

Authors:  Pedro Quimbar; Uru Malik; Christian P Sommerhoff; Quentin Kaas; Lai Y Chan; Yen-Hua Huang; Maresa Grundhuber; Kerry Dunse; David J Craik; Marilyn A Anderson; Norelle L Daly
Journal:  J Biol Chem       Date:  2013-04-02       Impact factor: 5.157

8.  An engineered cyclic peptide alleviates symptoms of inflammation in a murine model of inflammatory bowel disease.

Authors:  Claudia Cobos Caceres; Paramjit S Bansal; Severine Navarro; David Wilson; Laurianne Don; Paul Giacomin; Alex Loukas; Norelle L Daly
Journal:  J Biol Chem       Date:  2017-05-04       Impact factor: 5.157

9.  Clinical significance of kallikrein-related peptidase-4 in oral cancer.

Authors:  Petros Papagerakis; Giuseppe Pannone; L I Zheng; Maria Athanassiou-Papaefthymiou; Yashuo Yamakoshi; Howard Stan McGuff; Omar Shkeir; Konstantinos Ghirtis; Silvana Papagerakis
Journal:  Anticancer Res       Date:  2015-04       Impact factor: 2.480

10.  Associations between smoking and psychiatric comorbidity in U.S. Iraq- and Afghanistan-era veterans.

Authors:  F Joseph McClernon; Patrick S Calhoun; Jeffrey S Hertzberg; Eric A Dedert; Jean C Beckham
Journal:  Psychol Addict Behav       Date:  2013-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.